The Journal of Molecular Diagnostics is a premier publication in the fields of molecular medicine and pathology, published by Elsevier Science Inc. With an impressive impact factor and recognized as a Q1 journal in both Molecular Medicine and Pathology and Forensic Medicine, this journal is dedicated to advancing the understanding and application of molecular diagnostics in clinical practice. The journal features rigorous peer-reviewed research, comprehensive reviews, and cutting-edge methodologies that highlight novel diagnostic tests and biomarkers. Researchers, professionals, and students in the biomedical sciences are invited to explore its diverse array of articles and contribute to a growing body of knowledge critical for innovation in healthcare delivery. Located in the Netherlands, the journal has secure its position among the top-tier journals with its recent Scopus ranking of 20th out of 208 in Medicine Pathology and Forensic Medicine, reflecting a strong percentile ranking of 90th. With coverage spanning from 1999 to 2024, the Journal of Molecular Diagnostics remains a vital resource for anyone committed to the future of molecular research and diagnostics.

Annals of Diagnostic Pathology, published by Elsevier Science Inc, is a pivotal journal in the field of diagnostic pathology that has significantly contributed to the advancement of medical science since its inception in 1997. With an ISSN of 1092-9134 and E-ISSN of 1532-8198, this esteemed journal is positioned within the Q2 category in both Medicine (miscellaneous) and Pathology and Forensic Medicine, reflecting its high-quality research contributions, showcased by its ranking at #73 out of 208 in Scopus for the latter category. The journal's scope encompasses various aspects of diagnostic pathology, from innovative techniques to critical reviews of pathologic findings, making it an essential resource for researchers, medical professionals, and students dedicated to enhancing diagnostic accuracy and patient care. Although it does not currently offer open access options, its wide readership and impactful publications continue to influence clinical practices and research agendas. With a convergence period extending to 2024, Annals of Diagnostic Pathology remains a leading platform for disseminating valuable knowledge in this dynamic field.

Neurology-Genetics, an esteemed journal published by LIPPINCOTT WILLIAMS & WILKINS, is at the forefront of advancing the fields of neurology and genetics. With a dedicated Open Access model since 2015, this journal ensures that cutting-edge research is readily available to researchers, professionals, and students worldwide. Operating from the United States, Neurology-Genetics has established a reputable position within the scientific community, as reflected by its impressive rankings in Scopus; it holds a Q1 ranking in clinical neurology and a Q2 ranking in clinical genetics, showcasing its dual commitment to these intertwined fields. With an impact factor that continues to grow alongside its reach, the journal encourages the dissemination of novel findings, innovative methodologies, and critical reviews that contribute to the understanding and treatment of neurological and genetic disorders. Researchers and practitioners are invited to engage with the latest discoveries and discussions, making Neurology-Genetics an essential resource for anyone involved in these dynamic areas of study.

Cardiogenetics, published by MDPI, is a leading open-access journal dedicated to advancing the field of genetics as it pertains to cardiovascular health and diseases. Since its launch in 2011, this journal has been at the forefront of disseminating high-quality research that explores the genetic underpinnings of cardiovascular conditions, offering a platform for innovative studies, reviews, and case reports. With an ISSN of 2035-8253 and an E-ISSN of 2035-8148, Cardiogenetics aims to bridge the gap between genetic research and clinical application, helping researchers, healthcare professionals, and students stay abreast of the latest advancements and findings. The journal’s commitment to open access ensures that its valuable content is available to a global audience, fostering greater collaboration and knowledge sharing in the cardiovascular genetics community. By contributing to this dynamic field, Cardiogenetics plays a crucial role in improving patient outcomes and paving the way for personalized medicine in cardiology.

CYTOPATHOLOGY is a pivotal journal published by WILEY, focusing on the dynamic field of cytopathology within the broader medical and pathological sciences. Founded in 1990, this journal has become a crucial resource for researchers, professionals, and students interested in the microscopic examination of cell samples for diagnostic purposes. With an ISSN of 0956-5507 and E-ISSN of 1365-2303, CYTOPATHOLOGY is indexed in Scopus, where it currently holds a rank of #113 in Pathology and Forensic Medicine and #43 in Histology, placing it in the Q3 quartile for multiple categories in 2023. The journal publishes original research, reviews, and clinical studies that advance the understanding and application of cytopathology and its significance in health care. Although not an Open Access journal, its commitment to providing high-quality research makes it an essential platform for disseminating knowledge in the field. Researchers and practitioners looking to stay at the forefront of cytopathology developments will find CYTOPATHOLOGY to be an invaluable resource.

The Annals of Clinical Biochemistry, published by SAGE Publications Inc, is a prestigious journal that has been pivotal in advancing the field of clinical biochemistry since its inception. With an ISSN of 0004-5632 and an E-ISSN of 1758-1001, this journal provides a platform for high-quality, peer-reviewed research articles, reviews, and case studies that cover a wide range of topics, including biochemical analysis, diagnostic methodologies, and the latest advancements in clinical practices. As a recognized leader in the field, it holds a Q2 ranking in both Clinical Biochemistry and Miscellaneous Medicine categories, showcasing its contribution to the evolving landscape of medical science. The journal’s impact is further underscored by its strategic emphasis on fostering collaboration between researchers and healthcare professionals. Although it does not provide Open Access options, the accessible subscription model ensures that vital research remains within reach of academic and clinical institutions. The Annals of Clinical Biochemistry aims to promote the understanding and application of biochemical techniques in clinical settings, ensuring it remains an essential resource for researchers, professionals, and students alike.

Applied Immunohistochemistry & Molecular Morphology, published by Lippincott Williams & Wilkins, stands as a pivotal resource within the fields of histology, medical laboratory technology, and pathology. With an ISSN of 1541-2016 and an E-ISSN of 1533-4058, this journal has been contributing significant research and advancements since its inception in 1996. It serves a diverse audience, including researchers, professionals, and students, aiming to enhance the understanding of immunohistochemical techniques and molecular morphology. Recognized for its quality, it holds category quartiles of Q3 in histology and Q2 in medical laboratory technology and pathology and forensic medicine as of 2023. The journal's rigorous peer-review process ensures that only the most impactful findings are disseminated, thus advancing the education and practice in these critical domains of study. Though it is not an open-access journal, it remains essential for keeping abreast of the latest methodological innovations and applications in pathology and laboratory science, as evidenced by its respectable Scopus rankings and the continual convergence of groundbreaking research published through 2024.

JOURNAL OF DIAGNOSTIC MEDICAL SONOGRAPHY, published by SAGE PUBLICATIONS INC, is a critical platform for researchers, clinicians, and students in the field of sonography, offering insights and advancements in diagnostic imaging practices since its inception in 1985. With ISSN 8756-4793 and E-ISSN 1552-5430, this journal serves as a comprehensive resource addressing the latest trends, techniques, and technologies in radiological and ultrasound practices, despite being indexed in the lower quartiles yet maintaining a niche audience passionate about the evolution of sonographic methodologies. The journal's ongoing commitment to publishing high-quality research contributes significantly to its ranking within the competitive spheres of Radiology, Nuclear Medicine and Imaging and Radiological and Ultrasound Technology. As the field evolves, this journal aims to inspire dialogue, promote evidence-based practices, and enhance education among professionals dedicated to improving diagnostic accuracy and patient care in ultrasound technology.

JOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.

Annals of Laboratory Medicine, published by the KOREAN SOC LABORATORY MEDICINE, stands as a pivotal resource for researchers and practitioners in the fields of clinical and medical biochemistry. With a strong Q2 ranking in both Biochemistry (medical) and Clinical Biochemistry, along with a prestigious Q1 status in miscellaneous Medicine categories, this journal emphasizes the significance of laboratory medicine in improving patient outcomes and advancing scientific understanding. Established in 2012, the journal has demonstrated an impressive trajectory of growth and scholarly contribution, making it a reliable source of high-quality research and insightful reviews. The journal utilizes open access, enhancing the reach of its findings across the global scientific community. Operating from South Korea, Annals of Laboratory Medicine aims to foster dialogue and collaboration among professionals, contributing to the continuous advancement of laboratory methodologies and diagnostics.